Aesthetic treatments using stem cell derivatives—primarily exosomes and umbilical-cord fibroblasts—target skin ageing at the cellular level. Exosomes, tiny vesicles naturally released by stem cells, carry proteins and genetic material that may stimulate collagen production and improve skin texture. Umbilical-cord fibroblasts, harvested from donated umbilical tissue, are specialised cells responsible for maintaining skin structure in developing tissue. Placental extracts contain growth factors accumulated during foetal development. These cell-derived materials are investigated for reducing fine lines, improving elasticity, and enhancing overall skin luminosity. Unlike ablative procedures, they work by encouraging the skin's own repair mechanisms rather than removing tissue. Clinical interest has grown steadily, with 9 registered trials globally examining safety and efficacy across different age groups and skin types.
Nine registered clinical trials are currently tracking outcomes in aesthetic applications. Most focus on exosome infusions or fibroblast-derived serums applied topically or via micro-needling. Published studies report improvements in skin hydration, elasticity measurements, and subjective appearance scores over 8–12 weeks, though effect sizes vary. Placental extract trials have documented reductions in visible wrinkle depth in some cohorts. Evidence remains preliminary; long-term durability beyond 6 months is incompletely characterised. No major regulatory agency has approved stem cell-derived cosmetic products as therapeutic devices, though several are marketed as cosmeceuticals in jurisdictions with lighter oversight.
Aesthetic treatments typically cost €3,500–6,500 per session in European clinics, varying by cell type and delivery method. Exosome-based treatments are generally pricier (€5,000–7,000) owing to complex manufacturing. Fibroblast serums and placental extracts are moderately priced (€3,500–5,000). Multiple sessions over 3–6 months are often recommended. Insurance does not cover aesthetic procedures; costs are entirely out-of-pocket. Repeat treatments may be needed annually for sustained results, significantly increasing lifetime expenditure compared to conventional dermatology.
Cell therapy for Aesthetic & Anti-Ageing is offered as an individualised, physician-led programme. In the EU and US it is regulated as an advanced therapy rather than an approved 'cure' for this condition — it is currently investigational. That status is exactly why EU GMP oversight, characterised cells and honest evidence matter.
Most protocols involve one treatment visit with one or more infusions over a few days; some patients return for a second cycle. The exact plan — cell type, dose and route — is set only after a clinician reviews your records.
Eligibility depends on condition stage, age and overall health. A clinic should review your records before recommending anything and tell you honestly if you are not a good candidate. Our candidacy self-check gives an indicative read in 60 seconds.
An indicative Aesthetic & Anti-Ageing programme is €3,000–€8,000 for treatment (it varies by procedure). Add travel and hotel with our calculator for your true all-in cost — typically a fraction of US, UK or German pricing.
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
← Back to Aesthetic & Anti-Ageing overview · Aesthetic & Anti-Ageing cost →
Médecine régénérative certifiée GMP au cœur de l'UE — à partir de 3 000–8 000 €, une fraction des prix américains ou allemands. Protocoles personnalisés pour patients de plus de 50 pays.
Évaluation médicale gratuite